A5046059860- Zeolite Catalysis and Synthesis
- Mesoporous Materials and Catalysis
- Dendrimers and Hyperbranched Polymers
- SARS-CoV-2 and COVID-19 Research
- Retinal and Macular Surgery
- Nanoparticle-Based Drug Delivery
- Metal-Organic Frameworks: Synthesis and Applications
- Layered Double Hydroxides Synthesis and Applications
- Membrane Separation and Gas Transport
- COVID-19 Impact on Reproduction
- Retinal and Optic Conditions
- Corneal Surgery and Treatments
- Glaucoma and retinal disorders
Northwell Health
2021
Manhattan Eye, Ear and Throat Hospital
2021
CHA University
2020
Chonnam National University
2017-2018
We report the case of a 33-year-old woman with history hypothyroidism and ocular mild myopia who presented spontaneous filtering bleb. Extensive systemic rheumatologic evaluation was unrevealing. The bleb observed for many months, until patient’s vision declined secondary to development hypotony maculopathy. closed using an allogenic scleral patch graft, resulting in normotensive intraocular pressure improved best-corrected visual acuity. A unilateral, is rare occurrence typically associated...
The design of smart and functional nanocarriers for drug delivery systems that use a variety organic inorganic materials has led to the development nanomedicines with improved therapeutic efficiency reduced side effects. In this study, pH- temperature-responsive, controlled-release system high capacity loading was developed based on radially porous silica nanoparticles composed functionalized ligands polymer encapsulation. This uses oriented mesoporous as carrier, control surface chemistry...
The purpose of this article was to report a case full-thickness corneal transplant rejection 3 days after immunization with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Moderna mRNA-1273 vaccine.Case Report.A 51-year-old man history keratoconus and penetrating keratoplasty underwent repeat for graft failure. patient had an uncomplicated intraoperative postoperative course improved vision healthy graft. received SARS-CoV-2 vaccine on week 3, within days, began developing...